Tue.Jan 18, 2022

Bluebird faces longer wait for FDA verdict on experimental gene therapies

Bio Pharma Dive

The FDA has extended by three months its review of Bluebird's treatments for beta thalassemia and a rare brain disorder, the latest delay in the company's lengthy road to market in the U.S.

Can pharma really leverage social media?

World of DTC Marketing

A Mediabistro survey showed that social networks influence more than 40% of people’s health choices. Tik-Tok, Instagram, and other social media channels may soon be overwhelmed with pharma companies’ content, but is it a good idea?


Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Roche revives a closely watched Huntington's disease drug

Bio Pharma Dive

Ten months after Roche stopped giving the drug to patients in a Phase 3 trial, the pharma is planning a new study on the belief the medicine may help younger adult patients with less advanced disease

Trials 233

New study shows benefits of ammonium for pine root growth


In ecological terms, coniferous formations represent the biggest terrestrial carbon sink, they play an essential part in the pollination of the ecosystems where they grow and, moreover, help improve agricultural production.

2022 Research: The Rapid Rise of Ocean Freight Visibility

Download this a benchmark study from FourKites and The Journal of Commerce exploring how international shippers’ usage of global supply chain visibility technology has evolved since the onset of global disruptions caused by COVID-19.

FDA approves AbbVie, Pfizer drugs for eczema, creating competition for Sanofi

Bio Pharma Dive

AbbVie's Rinvoq and Pfizer's Cibinqo are both JAK-inhibiting drugs that are taken orally, a convenience which could help them compete against injectable treatments like Sanofi and Regeneron's Dupixent

More Trending

Leveraging print communications in support of clinical trial diversity

Bio Pharma Dive

Ensuring clinical studies reflect the real-world patient populations as much as possible in terms of ethnicity, race, sex and age

Parsa studying neuromorphic physics-informed stochastic regions of attraction through Bayesian optimization


Maryam Parsa, Assistant Professor, Electrical and Computer Engineering, received funding for the single-PI project: “Learning Neuromorphic Physics-Informed Stochastic Regions of Attraction through Bayesian Optimization” from Intel Corporation (INRC: Intel Neuromorphic Research Community).

How CRO venture capital relationships can help biotech fundraising

Bio Pharma Dive

A CRO can offer numerous services to biopharma and medical device companies, from drug discovery all the way through to commercialization, pharmacovigilance and post-approval activities

Drugs 208

Kernel flow: a wearable device for noninvasive optical brain imaging


Recent advances in brain imaging techniques facilitate accurate, high-resolution observations of the brain and its functions.


An Innovative & Creative Problem Solver Approach to Selling in the Medical Device Space

Speaker: Steve Goldstein, Sales Leader

Currently in sales or involved in a business that depends on strong sales results? Join Steve Goldstein, Sales Success Coach, Motivational Speaker and Medical Device Sales Leader from Gold Selling LLC. You will absorb critical strategies to become a trusted partner in greater sales success.

CVS Health and Microsoft alliance: an example of an extended partnership

Pharma Phorum

Microsoft and CVS Health have announced a new strategic alliance focusing on personalised care and accelerating digital transformation for the benefit of CVS customers and its employees.

Seeing inside cells with an integrated nanowire probe


The biological intracellular microenvironment is complex, made up of various cell compartments and intracellular substances. To fully characterize the physiological function of living cells, one of the key factors is the development of micro/nanoprobes for subcellular measurement.

Air of optimism surrounds lung cancer vaccine

Pharma Times

Cancer Research UK announces clinical trial for most common type of lung cancer

Why “data for good” initiatives mostly failed to impact the COVID-19 public health crisis – and how to improve


Inspired by their own experiences, representatives of a data-driven initiative to aid the COVID-19 response have outlined what they view as major obstacles to the successful use of novel data released by technology companies in times of crisis. Caroline Buckee of the Harvard T.H.

Mandatory COVID Vaccination Policy Template

The federal government is developing a rule requiring employers with more than 100 employees ensure their workers are vaccinated or produce a negative COVID test weekly before entering the workplace. So, what can your organization do to prepare? Get Paycor’s COVID Vaccination Policy Template to help communicate important details to your employees.

Europe launches initiative to transform clinical trials

BioPharma Reporter

Regulatory bodies in the European Union have launched an initiative to develop the region as a focal point for clinical research and to better integrate clinical research in the European health system. Clinical Development

UH engineers discover method to create upward water fountain in deep water


A pair of University of Houston engineers has discovered that they can create upward fountains in water by shining laser beams on the water’s surface.

Orgenesis and Johns Hopkins University create Maryland Center for Cell Therapy Manufacturing

BioPharma Reporter

Orgenesis and The Johns Hopkins University will construct a cell and gene therapy processing facility for point of care treatment of patients at Johns Hopkins. Upstream Processing

Case Western Reserve University research team identifies new mechanism for protecting DNA


CLEVELAND—Researchers from Case Western Reserve University have identified a new mechanism by which a protein known for repairing damaged DNA also protects the integrity of DNA by preserving its structural shape.

DNA 83

First-of-its-kind NHS gene pilot takes off

Pharma Times

The NHS launches world-first study investigating genetic testing for common diseases

Halting antibiotic resistance is a little less futile


HOUSTON – (Jan. 18, 2022) – A new experimental platform developed at Rice University promises to speed up the discovery of how infectious bacteria become resistant to antibiotics. Credit: Jeff Fitlow/Rice University HOUSTON – (Jan.

Pfizer: COVID-19 treatment shows promise against omicron variant

Outsourcing Pharma

The pharmaceutical company reports studies have demonstrated the main protease inhibitor of Paxlovid maintains in vitro efficiency against the variant. Preclinical Research

Building robust collaborations to “ATTACK” future pandemics


As the COVID-19 pandemic continues, the development of antiviral drug treatments has become a critical weapon in our arsenal against the virus.

Drugs 83

UK agency opens future of clinical trials to the public

Outsourcing Pharma

The Medicines and Healthcare Products Regulatory Agency has released proposals to bolster trials legislation, asking citizens for input on the suggestions. Markets & Regulations

On the tiniest of scales, chemistry isn’t all about “billiard-ball” reactions


Scientists are now one step closer to better understanding how to live in a “quantum” world — and not just from watching the character “Ant-Man” in the Marvel movie franchise.

Targeted agents and immunotherapies

Pharma Phorum

Targeted agents and immunotherapies are two of the most promising areas for significant advancements in cancer treatment.

Drugs 83

Citizen science helps nurture our health through nature


From lifting our moods, to boosting our immune systems, the intrinsic health benefits of being in nature are well known. But as urbanisation continues to encroach on green spaces, finding ways to connect with natural environments is becoming more challenging.


Digital health companies enabling R&D topped 2021 US investment, Rock Health says

Pharma Phorum

According to Rock Health’s annual digital health funding report, US-based digital health companies enabling life sciences research and development raised $5.8 billion (£4.3 billion) in 2021, making it the top funded category of the sector.

Atul Butte highlights regulatory, economic, and technical challenges in developing digital therapeutics


Article URL: [link] Credit: Brenda Miao, built using WordCloud 1.5.0 Article URL: [link] Article Title: Open challenges in developing digital therapeutics Author Countries: U.S.A. Funding: BM was supported by grants from the National Institutes of Health, USA (NIH grant 5T32GM67547-18).

NEW: The Drug Channels 2022 Video Webinar Series

Drug Channels

Join Dr. Adam J. Fein, CEO of Drug Channels Institute (DCI), for three live video webinars during 2022. These live, interactive events will be broadcast via Zoom from the Drug Channels Video studio in beautiful downtown Philadelphia. Click here to order the Drug Channels 2022 Video Webinar Series.

California Academy of Sciences receives largest private collection of Western aquatic invertebrates


SAN FRANCISCO, CA (January 18, 2022) — The California Academy of Sciences announced the Larry E. Serpa Western North America Aquatic Invertebrate Collection today in honor of late ecologist Larry Serpa, who passed away in May.

Engitix Announces $54m Series A Financing and a Strategic Collaboration with Dompé Farmaceutici Using Exscalate’s AI Supercomputing Power to Advance its Drug Discovery Pipeline in Fibrosis and Cancer

BioTech 365

Engitix Announces $54m Series A Financing and a Strategic Collaboration with Dompé Farmaceutici Using Exscalate’s AI Supercomputing Power to Advance its Drug Discovery Pipeline in Fibrosis and Cancer Engitix Announces $54m Series A Financing and a Strategic Collaboration with Dompé … Continue reading → Business Wire

Drugs 52

Carnegie Mellon-led research team selected to develop robotics technology to service satellites, build structures in orbit


There are 6,500 satellites in orbit, but only about half of them are functional. Once a satellite breaks down or runs out of fuel, it is essentially useless. Repairs, maintenance and upgrades are nearly impossible in orbit.